Boston Scientific Corp [BSX] stock is trading at $105.98, down -0.19%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BSX shares have gain 2.36% over the last week, with a monthly amount glided 11.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boston Scientific Corp [NYSE: BSX] stock has seen the most recent analyst activity on January 10, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $108 for it. Previously, Needham downgraded its rating to Hold on October 18, 2024. On May 30, 2024, Goldman initiated with a Buy rating and assigned a price target of $90 on the stock. Mizuho upgraded its rating to a Buy and increased its price target to $80 on February 01, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $59 as its price target on July 19, 2023. CL King started tracking with a Buy rating for this stock on June 30, 2023, and assigned it a price target of $64.
Boston Scientific Corp [BSX] stock has fluctuated between $64.54 and $107.17 over the past year. Currently, Wall Street analysts expect the stock to reach $100.22 within the next 12 months. Boston Scientific Corp [NYSE: BSX] shares were valued at $105.98 at the most recent close of the market. An investor can expect a potential drop of -5.43% based on the average BSX price forecast.
Analyzing the BSX fundamentals
Boston Scientific Corp [NYSE:BSX] reported sales of 16.75B for the trailing twelve months, which represents a growth of 22.44%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 105.44 points at the first support level, and at 104.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 106.34, and for the 2nd resistance point, it is at 106.69.
Ratios To Look Out For
For context, Boston Scientific Corp’s Current Ratio is 1.48. In addition, the Quick Ratio stands at 1.02 and the Cash Ratio stands at 0.42. Considering the valuation of this stock, the price to sales ratio is 9.33, the price to book ratio is 7.54 and price to earnings (TTM) ratio is 84.94.
Transactions by insiders
Recent insider trading involved LUDWIG EDWARD J, Director, that happened on Feb 11 ’25 when 12000.0 shares were purchased. EVP, Global Operations, Sorenson John Bradley completed a deal on Feb 07 ’25 to sell 6528.0 shares. Meanwhile, Officer JOHN B SORENSON bought 6528.0 shares on Feb 07 ’25.
